Healthcare Pathway and Costs Analysis in Patients With Metastatic Prostate Cancer (MPC)

Value in Health - United Kingdom
doi 10.1016/j.jval.2016.09.2168
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Immune Analysis of Radium-223 in Patients With Metastatic Prostate Cancer

Clinical Genitourinary Cancer
OncologyUrology
2018English

The Burden of Healthcare Costs Associated With Prostate Cancer in Ireland

Global and Regional Health Technology Assessment
Health Policy
2016English

Healthcare Costs of Depression in Patients Diagnosed With Cancer

Psycho-Oncology
PsychiatryMental HealthOncologyExperimentalCognitive Psychology
2018English

STAMPEDE Trial and Patients With Non-Metastatic Prostate Cancer – Authors' Reply

The Lancet
Medicine
2016English

Utility of Percutaneous Liver Ablation in Patients With Metastatic Prostate Cancer

Journal of Vascular and Interventional Radiology
Nuclear MedicineRadiologyCardiologyCardiovascular MedicineImagingMedicine
2016English

Managing Patients With Metastatic Prostate Cancer: Who Takes the Lead?

Trends in Urology & Men's Health
2017English

Burden and Timing of First and Subsequent Skeletal Related Events (SRES) in United States Elderly Men With Metastatic Prostate Cancer (MPC)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Analysis of Circulating Regulatory T Cells in Patients With Metastatic Prostate Cancer Pre- Versus Post-Vaccination

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2010English

89Zr-huJ591 Immuno-Pet Imaging in Patients With Advanced Metastatic Prostate Cancer

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy